Page last updated: 2024-11-05

brilliant black 1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID17294
CHEMBL ID1897478
CHEBI ID184515
SCHEMBL ID4207305
SCHEMBL ID4207318
SCHEMBL ID6120387
SCHEMBL ID8647387
SCHEMBL ID18775362
SCHEMBL ID19805036
MeSH IDM0040391

Synonyms (26)

Synonym
blue black bn
brilliant black bn
brilliant black
brilliant acid black bn extra pure a
food black 1
brilliant black a
brilliant acid black bna export
black bn
CHEBI:184515
n-{8-hydroxy-4,6-disulfo-7-[(e)-2-{7-sulfo-4-[(e)-2-(4-sulfophenyl)diazen-1-yl]naphthalen-1-yl}diazen-1-yl]naphthalen-1-yl}ethanimidic acid
4-acetamido-5-hydroxy-6-[[7-sulo-4-[(4-sulophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulonic acid
SCHEMBL4207305
SCHEMBL4207318
SCHEMBL6120387
SCHEMBL8647387
CHEMBL1897478
SCHEMBL18775362
4-acetamido-5-hydroxy-6-[[7-sulfo-4-[(4-sulfophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonic acid
4-(acetylamino)-5-hydroxy-6-[[7-sulfo-4-[(4-sulfophenyl)azo]-1-naphthalenyl]azo]-1,7-naphthalenedisulfonic acid, 9ci
e151
4-acetamido-5-hydroxy-6-({7-sulfo-4-[(4-sulfophenyl)diazenyl]naphthalen-1-yl}diazenyl)naphthalene-1,7-disulfonic acid
13699-36-0
DTXSID20859739
SCHEMBL19805036
4-acetamido-5-hydroxy-6-((7-sulfo-4-((4-sulfophenyl)diazenyl)naphthalen-1-yl)diazenyl)naphthalene-1,7-disulfonicacid
4-acetamido-5-hydroxy-6-((7-sulfo-4-((4-sulfophenyl)diazenyl)naphthalen-1-yl)diazenyl)naphthalene-1,7-disulfonic acid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" With the exception of the quinolines, food colors are relatively weak mutagens and are certified as safe additives despite reports that some people have allergic reactions to them."( The evaluation of the genotoxicity of two commonly used food colors: Quinoline Yellow (E 104) and Brilliant Black BN (E 151).
Kononowicz, AK; Macioszek, VK, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]